Malignant Pleural Mesothelioma Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working

“DelveInsight Business Research LLP” DelveInsight’s ‘Malignant Pleural Mesothelioma (MPM)-Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the MPM, historical and forecasted epidemiology as well as the MPM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan. DelveInsight has launched a new report on “Malignant … Read more

Malignant Pleural Effusion Clinical and Non-Clinical Studies…

(MENAFN- GetNews) Malignant Pleural Effusion Pipeline Insight, 2021″ report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Malignant Pleural Effusion Market. The Malignant Pleural Effusion Pipeline report embraces in-depth commercial and clinical assessment of the Malignant Pleural Effusion pipeline products from the pre-clinical developmental phase to the marketed … Read more

Immunotherapy combination maintains OS advantage in malignant pleural mesothelioma

September 17, 2021 3 min read Source/Disclosures Published by: Source: Peters S, et al. Abstract LBA65. Presented at: European Society for Medical Oncology Congress (virtual meeting); Sept. 17-21, 2021. Disclosures: Bristol Myers Squibb funded this study. Peters reports relationships with several pharmaceutical companies, including Bristol Myers Squibb. Please see the abstract for all researchers’ relevant … Read more

Access to care varies greatly among patients with malignant pleural mesothelioma

September 14, 2021 3 min read Source/Disclosures Published by: Source: Rodriguez E, et al. Abstract OA13.02. Presented at: International Association for the Study of Lung Cancer World Conference on Lung Cancer (virtual meeting); Sept. 8-14, 2021. Disclosures: Rodriguez reports a consultant/advisory board role with AstraZeneca, as well as speakers bureau roles with OncLive, Research to … Read more